Cryofocus Medtech (Shanghai) Co. Ltd. Class H (HK:6922) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cryofocus Medtech (Shanghai) Co., Ltd. successfully conducted its 2023 Annual General Meeting, H Share Class Meeting, and Unlisted Share Class Meeting, with shareholders approving all proposed resolutions. High turnouts were observed, with approximately 76.73% of total shares represented at the AGM, 60.41% of H Shares at their respective meeting, and a notable 91.63% of Unlisted Shares. The meetings marked the re-election of the company’s directors and supervisors, indicating stable governance and shareholder support.
For further insights into HK:6922 stock, check out TipRanks’ Stock Analysis page.